Tag: Fundraising

Earlier this month, Impetus Grants announced its third round of funding, with 10 million from the Rosenkranz and Hevolution foundations. Previously, the program conducted two grant rounds, bringing 114 new projects and 50 new labs into the space, giving away more than 24 million dollars for a “new kind of science”. Now, some of these...

We have two scientific research projects in the new Gitcoin fundraising round. Help us to combat Alzheimer's disease or improve how clinical trials are conducted today! An alternative way to fund science Gitcoin is a decentralized science (DeSci) platform that utilizes blockchain technology to support the development of open-source projects using Web3 technologies, with the...

VitaDAO, a decentralized organization funding early-stage longevity research and biotech start-ups, has announced the successful closing of a $4.1 million funding round dedicated to financing future longevity projects and furthering its commercialization and licensing strategy for IP-NFT assets. Key contributors to the fundraising round include Shine Capital, L1 Digital, decentralized science and Web3 organizations Beaker...

In 2021, the cryptocurrency market was estimated as having a market capitalization of around $3 trillion, almost equal to the UK’s nominal GDP of $3.2 trillion. Since then, the estimated value of this market has dropped to $1 trillion, which, if it were a country, would still place it within the top 20 in terms...

Gitcoin has launched its 15th funding round and is again supporting projects focused on aging and rejuvenation. An alternative way to fund science Gitcoin is a platform focused on supporting the development of open-source Web3 software. This is a decentralized system based on blockchain technology with the goal of funding "public good" projects that are...

We have written extensively about VitaDAO, a collective dedicated to community-governed, decentralized drug development. Probably the fastest and cheapest way to get geroprotective drugs to the market is by repurposing existing drugs, such as rapamycin, metformin, and acarbose. These drugs cost next to nothing, have a known safety record, and have shown a lot of...